SYNTHESIS AND BIOLOGICAL ACTIVITY OF THE TWO ISOMERIC 2'-C-METHYL DAUNOMYCINS
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Institut de Chimie des Substances Natureljes du C.N.R.S., 91 198 Gif-sur-Yvette Cedex, France (Received for publication November 30, 1988) The title new daunorubicin analogues have been prepared from methyl 4,6-0-benzylidene-2-C-methyl-a-D-r/Z?o-hexopyranosid-3-ulose and daunomycinone. The antitumor activity of these compounds was very similar to that of daunorubicin. 1393 The antibiotic daunorubicin (1) is a clinically useful antineoplastic agent.0 As part of a program directed toward the synthesis of analogues of 1,2>3) modified in the amino-sugar moiety, we report now the synthesis of (2'jR)-2'-C-methyl (17) and (2/*S)-2/-C-methyl daunomycin (18). In view of the excellent antitumor activity of S'-C-methyl daunomycin (2)3) the synthesis of 17 was undertaken in order to explore the biological properties of another daunorubicin analogue in which the C-3' amino group would be more hindered than in the natural product. The formation of 18 is unexpected.
Chemistry
The known methyl 4,6-0-benzylidene-2-C-methyl-a-D-n7>0-hexopyranosid-3-ulose (4)4) was converted to its oxime 5 and the latter was reduced with sodium bis(2-methoxyethoxy)aluminum hydride (Red-Al) to the v>-allo amine 6. Protection of the amine by iV-trifluoroacetylation gave 7
and iV-bromosuccinimide induced opening of the 4,6-0-benzylidene acetal system furnished 8. Dehydrobromination of 8 in the presence of silver fluoride afforded the unsaturated compound 9.
The double bond of 9 was stereospecifically reduced by hydrogenation to give the fi-L-talo derivative 10. Evidence for the L-talo configuration of 10 was furnished by its XHNMRspectrum which revealed at 5.30 ppm a narrow triplet type signal for 4-H. The small (3/4,5=4 Hz) coupling constant between 4-H and 5-H of 10 was indicative of a as-relationship between these hydrogen atoms.
Methyl 4-O-benzoyl-2-C-methyl-2, 3 , 6-trideoxy-3-trifluoroacetamido-/3-L-/a/ohexopyranoside (10) was transformed in two steps, by treatment with aqueous acetic followed by acetylation, into an anomeric mixture of l -O-acetyl-4-O-benzoyl-2-C-methyl-2,3 , 6-trideoxy-3-trifluoroacetamido-L-rfl/o-hexopyranosides (ll). This mixture was used, without further purification, for the glycosidation reaction. Glycosylation of daunomycinone (3) by ll was accomplished in 30% yield, with anhydrous^-toluene sulfonic acid (PTSA).
The reaction furnished three isomeric glycosylation products. These compounds, 12, 13 and 14 were separated by preparative TLCand their structure established by NMR spectroscopy.
Inspection of the mass and 13C NMRspectra of the glycosylation products revealed that in addition to the expected product 12 two other isomeric compounds 13 and 14 were formed during the reaction. The sugar configuration of 13 was determined to be L-galacto. The partial C-2 methyl isomerization, a result of the 1,3-diaxial interaction between the C-2 and C-4 substituents of ll, has taken place during the reaction which liberated the anomeric hydroxy group. The configuration of the THE JOURNAL OF ANTIBIOTICS SEPT. 1989 carbohydrate constituent of 14 was L-talo, as in the starting material, however, the sugar was present in the furanose form. The 13C and XHNMRspectrum of the three glycosylation products 12, 13 and 14 revealed structurally diagnostic signals. The 13C NMRspectrum of 12 and 13 appeared characteristic of daunomycinone 7a:-glycosides. These compoundswere differentiated on the basis of *HNMRdouble resonance experiments. The anomeric proton of both compoundsshowed a broad singlet indicating the nature of the glycosidic linkage. However, upon irradiation of the C-2'-methyl group signal large and small 3/2,3 proton coupling constants could be revealed, respectively, in the spectrum of 12 and 13. In view of the axially disposed C-4' substituent only small 13C NMRchemical shift differences were expected in the spectrum of 12 and 13 for C-2' and C-4'. The 13C NMRspectrum of 14 revealed a typical furanose signal at 87.2 ppm for C-4' and the XHNMRspectrum of 14 showed a characteristic down field 5' -H signal at 5.35 ppm. Elimination of the base sensitive C-3' and C-4' protecting groups of 12 and 13 was found to proceed more efficiently in two steps rather than in a single step. As the free amines proved to be slightly unstable, their hydrochlorides 17 and 18 were prepared for the biological experiments. Studies on the furanoside 14 were not continued further.
Biological Properties The cytostatic activity of both 2/-C-methyl daunomycin hydrochlorides 17 and 18 against P388 leukemia cells in vitro was approximately identical with that of daunorubicin (1).
Experi mental General Procedures
The mp's were determined with a Buchi apparatus and are uncorrected. (21 To a solution of 4 (1 g, 3.6 mmol) in dry pyridine (25 ml) was added hydroxylamine hydrochloride (860 mg, 13.7 mmol) and the mixture was stirred at room temperature for 5 hours. After standard workup a crystalline mixture of cis and trans oximes 5 (1 g, 95%) was obtained. A 70%solution of Red-Al in dry toluene (4.4ml, 15.4mmol) was added to a solution of 5 (1 g, 3.3 mmol) in toluene (10 ml) at -40°C.5) Stirring was maintained at -40°C for 0.5 hour and then at room temperature for 2 hours. After extractive isolation, the unstable amine 6 (825 mg, 90%) was obtained. Dry pyridine (10 ml) and trifluoroacetic anhydride (1.4 ml, 10 mmol) were successively added to a stirred solution of amine 6 (825 mg, 2.97 mmol) in ether (20 ml) at -40°C. After 5 hours at 0°C, after dissolution in ether, the organic layer was washed, dried over MgSO4and concentrated in vacuo. Flash chromatography, using hexane -ethyl acetate (4 : 6), gave pure crystalline 7 (1 g, 92%): MP 1001 Methyl 4-O-Benzoyl-2-C-methyl-2, 3 ,6-trideoxy-3-trifluoroacetamido^L-^/o-hexopyranoside (10) A suspension of 7 (1.3 g, 3.4 mmol) and iV-bromosuccinimide (720 mg, 4.1 mmol) in anhydrous SEPT. 1989 carbon tetrachloride (32 ml) was refluxed overnight in an argon atmosphere. After cooling and filtration through kieselguhr, the organic layer was washed with a solution of sodium thiosulfate. Extractive isolation gave crude 8 which, without further purification, was treated as follows. A mixture of 8 (1 g, 2.2 mmol) and silver fluoride (1.95 g, 15.4 mmol) in dry pyridine (100ml) was stirred in the dark for 3 days. The resulting mixture was then diluted with ether, filtered through kieselguhr, concentrated and purified by flash chromatography using hexane -ethyl acetate (8 : 2) giving pure 9 (560mg, 68%). A mixture of 9 (1 g, 2.7mmol) in methanol (50ml) and 5% Pd-C (75mg) was hydrogenated overnight at atmospheric pressure. Filtration on kieselguhr and concentration gave a residue which was purified by flash chromatography using pentane -ether (9 : 1). 
A solution of 10 (500 mg, 1.35 mmol) in 20% acetic acid in water (18 ml) was stirred under reflux for 36 hours. After cooling, the mixture was evaporated below 30°C to give a yellow solid. The latter was dissolved in pyridine (20 ml) and acetic anhydride was added to the solution while keeping the temperature at 0°C. After 5 hours the mixture was worked up to furnish ll (490 mg, 90%). To a solution of daunomycinone (3) (450 mg, 1.15 mmol) and anhydrous PTSA (680 mg, 3.45 mmol) in dry dichloromethane (50 ml) and toluene (50 ml) was added dropwise in an argon atmosphere the acetylated sugar ll (1 g, 2.30 mmol) in dichloromethane (5 ml). After stirring for 5 hours at room temperature in the dark, the mixture was diluted with dichloromethane (150 ml), washed successively with a 5% aqueous solution of sodium hydrogen carbonate and the organic layer was dried over MgSO4. The residue was flash chromatographed to afford 12 (175 mg, 50%), 13 (105 mg, 30%) and 7 -O -(3/-Amino -2/-C"methyl-2/,3^6/-trideoxy> a -L-^/<9-pyranosyl)daunomycinone Hydrochloride (17) and 7-O<3/-Amino>2/-C-methyl-2^3^6/-trideoxy-Q;-L-^/^c^-pyranosyl)daunomycinone Hydrochloride
A solution of 12 (or 13) (80mg, 0.18mmol) in 0.1 n sodium hydroxide in water (6.5ml) was stirred at room temperature in an argon atmosphere for 10 minutes. The reaction was then quenched by dropwise addition of 0.1 n hydrochloric acid until pH 5. Dilution with dichloromethane was followed by extractive isolation. The crude product was purified by preparative TLC, using dichloromethane -methanol (97 :3), to afford pure 15 (40 mg, 61 %): [afi +189°(c 0.ll, CHC15); FAB-MS m/z 637 (M+) or pure 16 (43 mg, 62%): MP 142°C; H2D2 +206°(c 0.44, CHC13); FAB-MS m/z 637 (M+). To a solution of 15 (or 16) (12 mg, 0.02 mmol) in methanol (2 ml) was added a 0.1 n solution of barium hydroxide in water (1.2 ml). The mixture was stirred at room temperature for 1.5 hours. The pH was adjusted to 5 by dropwise addition of a 0.1 n solution of hydrochloric acid in water. Dilution with dichloromethane was followed by extractive isolation. The free amine (10 mg, 95 %), was treated in dichloromethane solution with a 0.25 n solution of hydrogen chloride in CH2C12. After evaporation of the solvent, the antibiotic hydrochloride 17 (or 18) crystallized from methanolether.
